Codrituzumab (Synonyms: GC33; RO5137382) |
Catalog No.GC68889 |
Codrituzumab es un anticuerpo monoclonal dirigido contra GPC3 (glicoproteína-3). GPC3 es una proteína embrionaria cancerosa que se expresa en la superficie de las células del cáncer hepático (HCC). Codrituzumab induce citotoxicidad dependiente de anticuerpos (ADCC) y suprime el crecimiento tumoral.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1365267-33-9
Sample solution is provided at 25 µL, 10mM.
Review for Codrituzumab
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for Codrituzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *